Mildly elevated liver enzymes are one of the most common abnormal results on an executive or longevity panel. In many of those patients, the underlying issue turns out to be fat in the liver, now called metabolic dysfunction-associated steatotic liver disease, or MASLD. Patients often ask for “a scan of the liver” right away. Sometimes that is exactly the right next step; sometimes a blood-based score should come first.
This guide outlines where abdominal ultrasound fits in the evaluation of abnormal liver tests and suspected MASLD, based on current liver society guidance, and how a mobile abdominal study can support concierge and longevity practices.
The new terminology
In 2023, a multi-society consensus replaced “nonalcoholic fatty liver disease” (NAFLD) with MASLD: hepatic steatosis plus at least one cardiometabolic risk factor, such as overweight, elevated glucose or diabetes, high blood pressure, high triglycerides or low HDL. A related category, MetALD, describes patients with MASLD who also drink more alcohol than the low-risk thresholds. The change emphasizes what matters clinically: metabolic risk and fibrosis.
Fibrosis drives outcomes, so risk-stratify first
The amount of fat in the liver matters less for long-term outcomes than the degree of fibrosis. AASLD’s 2023 practice guidance recommends a stepwise approach for patients at risk: start with FIB-4, a score calculated from age, AST, ALT and platelets. A low FIB-4 generally indicates low risk of advanced fibrosis. Indeterminate or high scores lead to a second test, usually vibration-controlled transient elastography or a blood-based fibrosis marker, and referral to hepatology when advanced fibrosis is likely.
Conventional B-mode ultrasound is not a fibrosis test. It can show steatosis and signs of advanced disease, but it cannot reliably stage fibrosis in the middle range.
Where abdominal ultrasound does help
- Abnormal liver tests of unclear cause. Ultrasound evaluates the liver, gallbladder, bile ducts and pancreas in one study and can show biliary dilation, gallstones, focal liver lesions or a cholestatic pattern that changes the work-up.
- Documenting steatosis. Moderate to severe steatosis shows as a bright, echogenic liver with reduced visualization of deeper structures. Ultrasound is less sensitive for mild steatosis.
- Signs of advanced disease. A nodular liver surface, enlarged spleen, reversed portal flow or ascites raise concern for cirrhosis and portal hypertension.
- Focal lesions. Many incidental liver lesions, such as cysts and typical hemangiomas, are characterized on ultrasound; others need CT or MRI.
- Surveillance in cirrhosis. For patients with established cirrhosis, liver societies recommend ultrasound surveillance for hepatocellular carcinoma about every six months, with or without AFP.
A practical sequence
Many concierge and longevity physicians follow a sequence like this for a patient with mildly elevated enzymes and metabolic risk factors:
- Repeat labs and review alcohol, medications and supplements.
- Screen for other causes as indicated, such as viral hepatitis or iron overload.
- Calculate FIB-4.
- Order an abdominal ultrasound if there is a structural question, if enzymes are disproportionately cholestatic, if steatosis needs documenting, or if FIB-4 or exam findings suggest advanced disease.
- Refer for elastography or hepatology when FIB-4 is indeterminate or high.
The order should state the clinical question: “elevated ALT and AST, rule out biliary obstruction and assess for steatosis,” for example. That helps the radiologist focus the report.
Preparation and the visit
An abdominal ultrasound requires fasting: no food for 8 hours before; water is fine. The study takes 30 to 45 minutes and evaluates the liver, gallbladder, bile ducts, pancreas, spleen, kidneys and abdominal aorta. Patients with diabetes should follow their physician’s instructions on fasting and medication timing.
What the report will and will not tell you
The radiologist report describes liver size and echogenicity, any focal lesions, bile duct caliber, the gallbladder, spleen size and other organs. It may describe steatosis as mild, moderate or severe. It will not give a fibrosis stage. Follow-up recommendations for incidental findings will be included where appropriate. The ordering physician interprets the report in the context of the labs and risk scores.
Gallbladder and bile duct findings
Abnormal liver tests are not always about the liver. A cholestatic pattern, with alkaline phosphatase and bilirubin elevated out of proportion to the transaminases, points toward the biliary tree. Ultrasound is the first-line imaging test for that question. It shows gallstones, gallbladder wall thickening, sludge and dilation of the common bile duct. A dilated duct with abnormal labs usually leads to further imaging, such as MRCP, and specialist referral. Gallbladder polyps, another common incidental finding, are followed or referred according to their size and features.
Incidental liver lesions
Abdominal ultrasound performed for liver tests frequently finds something else: simple liver cysts, hemangiomas, areas of focal fatty sparing or focal fat. Many are clearly benign on ultrasound. Others are indeterminate and need contrast-enhanced CT or MRI for characterization, particularly in patients with cirrhosis, cancer history or abnormal tumor markers. The radiologist’s report will say which category a lesion falls into and whether further imaging is recommended.
Spleen and portal circulation
Spleen size is a simple and useful measurement. An enlarged spleen in a patient with fatty liver and a low platelet count raises concern for portal hypertension and advanced fibrosis. Doppler assessment of the portal vein can show slow or reversed flow. These findings change the urgency of hepatology referral, which is why the order should note platelet count and any prior imaging.
Alcohol and MetALD
Many executive patients drink regularly, and the new nomenclature makes room for that: MetALD describes patients with metabolic risk factors who also drink above low-risk thresholds. Ultrasound findings look the same; what changes is the conversation. Physicians may find the category a helpful way to discuss alcohol as one of several modifiable factors.
Repeat imaging
Steatosis can improve with weight loss, exercise and treatment of metabolic risk factors. Some practices use repeat ultrasound to show patients progress, though changes in grade on ultrasound are subjective. When quantification matters, elastography-based measurements of fat and stiffness are more reproducible.
Preparing the patient
Patients get the most from an abdominal study when they arrive prepared and informed. Tell them to fast for 8 hours, drink water as usual, take essential medications with water unless instructed otherwise, and expect the sonographer to ask them to hold their breath for some images. Explain that the sonographer will not discuss results, and tell them when your office will call. Patients with diabetes should have specific instructions about fasting and medication timing.
When the answer is CT or MRI
Ultrasound is often the right first test, but it is not always the last. Body habitus and bowel gas can limit views of the pancreas and deeper structures. Indeterminate liver lesions, suspected pancreatic disease and complex biliary questions usually need CT, MRI or MRCP. The radiologist’s report will say when views were limited or when another modality would add information, and the ordering physician can arrange that study at an imaging center.
Knowing these limits in advance helps the physician set expectations with the patient: ultrasound answers many liver and gallbladder questions quickly and without radiation, and a second study, if needed, is a normal part of a careful work-up rather than a sign that something was missed.
Ordering an abdominal study at home or the office
UltraVision Imaging performs complete and limited abdominal ultrasound at patients’ homes and offices for concierge, longevity and private-medicine practices across Los Angeles, San Diego County, Orange County and Palm Springs, the Bay Area and the Sacramento region. Elastography is typically done at a hepatology practice or imaging center. A board-certified radiologist reads every study and the report goes to the ordering physician. See every region on our page for physicians. Our team will be in touch to coordinate scheduling.
Frequently asked questions
What is MASLD?
Metabolic dysfunction-associated steatotic liver disease, the 2023 name for fatty liver disease in people with at least one cardiometabolic risk factor.
Is ultrasound the first test for suspected MASLD?
Current AASLD guidance starts risk stratification with FIB-4. Ultrasound helps with structural questions, documenting steatosis and signs of advanced disease.
Can ultrasound stage liver fibrosis?
Conventional ultrasound cannot reliably stage fibrosis. Elastography or blood-based fibrosis markers are used for that.
Does an abdominal ultrasound require fasting?
Yes. No food for 8 hours before; water is fine. Patients with diabetes should follow their physician’s instructions.
What else does an abdominal ultrasound check?
The gallbladder, bile ducts, pancreas, spleen, kidneys and abdominal aorta, in addition to the liver.
How often is ultrasound used in cirrhosis?
Liver societies recommend ultrasound surveillance for liver cancer about every six months in patients with cirrhosis.
Sources
- Rinella ME et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023
- Rinella ME et al. AASLD practice guidance on the clinical assessment and management of NAFLD. Hepatology 2023
- Singal AG et al. AASLD practice guidance on prevention, diagnosis and treatment of hepatocellular carcinoma. Hepatology 2023
- RadiologyInfo.org (ACR and RSNA): Abdominal ultrasound
This article is general information for licensed clinicians and practice staff. It is not medical or legal advice and does not replace clinical judgment. UltraVision Imaging performs diagnostic ultrasound; a board-certified radiologist interprets every diagnostic study, and the ordering physician directs care.